The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Riley RS, June CH, Langer R, et al. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18(3):175–196.
   PubMed Web of Science ®Google Scholar
• How CW, Ong YS, Low SS, et al. How far have we explored fungi to fight cancer? [published online ahead of print, 2021 Mar 15. Semin Cancer Biol. 2021;S1044-579X(21)00059–6. DOI:10.1016/j.semcancer.2021.03.009
   PubMedGoogle Scholar
• Boubrik F, Belmouden A, Kadmiri NE. Potential non-invasive biomarkers of helicobacter pylori-associated gastric cancer [published online ahead of print, 2021 Nov 12]. J Gastrointest Cancer. 2021. DOI:10.1007/s12029-021-00734-7
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. Intraperitoneal delivery of chemotherapeutic agents for the treatment of peritoneal metastases: current challenges and how to overcome them. Expert Opin Drug Deliv. 2019;16(12):1393–1401.
   PubMed Web of Science ®Google Scholar
• Xu H, Xiong C, Chen Y, et al. Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma. Bioengineered. 2021;12(1):2664–2675.
   PubMed Web of Science ®Google Scholar
• Itoh G, Chida S, Yanagihara K, et al. Tanaka M.Cancer-associated fibroblasts induce cancer cell apoptosis that regulates invasion mode of tumours. Oncogene. 2017 Aug;36(31):4434–4444.
   PubMed Web of Science ®Google Scholar
• Becerril-Rico J, Alvarado-Ortiz E, Toledo-Guzmán ME, et al. The cross talk between gastric cancer stem cells and the immune microenvironment: a tumor-promoting factor. Stem Cell Res Ther. 2021;12(1):498.
   PubMed Web of Science ®Google Scholar
• Yang Z, OuYang X, Zheng L, et al. Long intergenic noncoding RNA00265 promotes proliferation of gastric cancer via the microRNA-144-3p/Chromobox 4 axis. Bioengineered. 2021;12(1):1012–1025.
   PubMed Web of Science ®Google Scholar
• Begolli R, Sideris N, Giakountis A. LncRNAs as chromatin regulators in cancer: from molecular function to clinical potential. Cancers (Basel). 2019;11(10):1524.
   PubMed Web of Science ®Google Scholar
• Ye J, Li J, Zhao P. Roles of ncRNAs as ceRNAs in Gastric Cancer. Genes (Basel). 2021;12(7):1036.
   PubMed Web of Science ®Google Scholar
• Li H, Wang X, Wen C, et al. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Mol Cancer. 2017;16(1):169.
   PubMedGoogle Scholar
• Zhang J, Li XY, Hu P, et al. lncRNA NORAD contributes to colorectal cancer progression by inhibition of miR-202-5p. Oncol Res. 2018 Oct 17;26(9):1411–1418.
   PubMed Web of Science ®Google Scholar
• Tao W, Li Y, Zhu M, et al. LncRNA NORAD promotes proliferation and inhibits apoptosis of gastric cancer by regulating miR-214/Akt/mTOR Axis. Onco Targets Ther. 2019 Oct 30;12:8841–8851.
   PubMed Web of Science ®Google Scholar
• Miao Z, Guo X, Tian L. The long noncoding RNA NORAD promotes the growth of gastric cancer cells by sponging miR-608. Gene. 2019 Mar 1;687:116–124.
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017 Mar;16(3):203–222.
   PubMed Web of Science ®Google Scholar
• Pajares MJ, Alemany-Cosme E, Goñi S, et al. Epigenetic Regulation of microRNAs in cancer: shortening the distance from bench to bedside. Int J Mol Sci. 2021;22(14):7350.
   PubMed Web of Science ®Google Scholar
• Qing Z, Huang H, Luo Q, et al. Hypoxia promotes the proliferation of mouse liver sinusoidal endothelial cells: miRNA-mRNA expression analysis. Bioengineered. 2021;12(1):8666–8678.
   PubMed Web of Science ®Google Scholar
• Pei Y, Tang Z, Cai M, et al. MicroRNA miR-425 promotes tumor progression by inhibiting Dickkopf-related protein-3 in gastric cancer. Bioengineered. 2021;12(1):2045–2054.
   PubMed Web of Science ®Google Scholar
• Hu S, Zheng Q, Wu H, et al. miR-532 promoted GC migration and invasion by targeting NKD1. Life Sci. 2017 May 15;177:15–19.
   PubMed Web of Science ®Google Scholar
• Li Y-S, Zou Y, Dai D-Q. MicroRNA-320a suppresses tumor progression by targeting PBX3 in GC and is downregulated by DNA methylation.World. J Gastrointest Oncol. 2019;11(10):842–856.
   PubMed Web of Science ®Google Scholar
• Cui L, Wang P, Ning D, et al. Identification of a novel prognostic signature for gastric cancer based on multiple level integration and global network optimization. Front Cell Dev Biol. 2021;9:631534.
   PubMed Web of Science ®Google Scholar
• Dou D, Ren X, Han M, et al. Cancer-associated fibroblasts-derived exosomes suppress immune cell function in breast cancer via the miR-92/PD-L1 pathway. Front Immunol. 2020;11:2026.
   PubMed Web of Science ®Google Scholar
• Lai F, Zhang H, Xu B, et al. Long non-coding RNA NBR2 suppresses the progress of colorectal cancer in vitro and in vivo by regulating the polarization of TAM. Bioengineered. 2021;12(1):5462–5475.
   PubMed Web of Science ®Google Scholar
• Yu J, Ni Q, Zhang S, et al. MicroRNA-92a promotes proliferation and invasiveness of gastric cancer cell by targeting FOXO1 gene. Cell Mol Biol (Noisy-le-grand). 2020;66(1):95–100.
   PubMed Web of Science ®Google Scholar
• Papadaki C, Monastirioti A, Rounis K, et al. Circulating MicroRNAs Regulating DNA damage response and responsiveness to cisplatin in the prognosis of patients with non-small cell lung cancer treated with first-line platinum chemotherapy. Cancers (Basel). 2020;12(5):1282.
   PubMed Web of Science ®Google Scholar
• Ishiguro N, Moriyama M, Furusho K, et al. Activated M2 macrophages contribute to the pathogenesis of IgG4-Related Disease via Toll-like Receptor 7/Interleukin-33 Signaling. Arthritis Rheumatol. 2020;72(1):166–178.
   PubMed Web of Science ®Google Scholar
• Shang D, Liu Y, Zhang J, et al. Peroxisome proliferator-activated receptor γ (PPARγ) suppresses the proliferation and metastasis of patients with urothelial carcinoma after renal transplantation by inhibiting LEF1/β-catenin signaling. Bioengineered. 2020;11(1):1350–1367.
   PubMed Web of Science ®Google Scholar
• Ren J, Ding L, Zhang D, et al. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19. Theranostics. 2018;8(14):3932–3948.
   PubMed Web of Science ®Google Scholar
• Shang J, Sun S, Zhang L, et al. miR-211 alleviates ischaemia/reperfusion-induced kidney injury by targeting TGFβR2/TGF-β/SMAD3 pathway. Bioengineered. 2020;11(1):547–557.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Wei D, He X, et al. Phillyrin prevents neuroinflammation-induced blood-brain barrier damage following traumatic brain injury via altering microglial polarization. Front Pharmacol. 2021;12:719823.
   PubMed Web of Science ®Google Scholar
• Pan W, Li W, Zhao J, et al. lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway. Mol Oncol. 2019;13(10):2246–2258.
   PubMed Web of Science ®Google Scholar
• Landskron G, De La Fuente López M, Dubois-Camacho K, et al. Corrigendum: interleukin 33/ST2 axis components are associated to desmoplasia, a metastasis-related factor in colorectal cancer. Front Immunol. 2019;10:2149.
   PubMed Web of Science ®Google Scholar
• Zhao R, Yu Z, Li M, et al. Interleukin-33/ST2 signaling promotes hepatocellular carcinoma cell stemness expansion through activating c-Jun N-terminal kinase pathway. Am J Med Sci. 2019;358(4):279–288.
   PubMed Web of Science ®Google Scholar
• Zhang H, Deng T, Liu R, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19(1):43.
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhang J, Hou L, et al. LncRNA AK023391 promotes tumorigenesis and invasion of GC through activation of the PI3K/Akt signaling pathway. J Exp Clin Cancer Res. 2017 Dec 28;36(1):194.
   PubMedGoogle Scholar
• Mao Z, Li H, Du B, et al. LncRNA DANCR promotes migration and invasion through suppression of lncRNA-LET in GC cells. Biosci Rep. 2017 Nov6;37(6):20171070.
   Google Scholar
• Guo T, Yuan X, Liu DF, et al. LncRNA HOXA11-AS promotes migration and invasion through modulating miR-148a/WNT1/β-catenin pathway in gastric cancer. Neoplasma. 2020;67(3):492–500.
   PubMed Web of Science ®Google Scholar
• Song Q, Geng Y, Li Y, et al. Long noncoding RNA NORAD regulates MPP+-induced Parkinson’s disease model cells. J Chem Neuroanat. 2019 Nov;101:101668.
   PubMed Web of Science ®Google Scholar
• Qi H, Yao L, and Liu Q. NORAD affects the progression of diabetic nephropathy through targeting miR-520h to upregulate TLR4. Biochem Biophys Res Commun. 2020 Jan 1; 5212: 190–195.
   PubMedGoogle Scholar
• Yang Z, Zhao Y, Lin G, et al. Noncoding RNA activated by DNA damage (NORAD): biologic function and mechanisms in human cancers. Clin Chim Acta. 2019 Feb;489:5–9.
   PubMed Web of Science ®Google Scholar
• Mollica Poeta V, Massara M, Capucetti A, et al. Chemokines and chemokine receptors: new targets for cancer immunotherapy. Front Immunol. 2019;10:379.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yue J, Jiang Z, et al. CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma. Cell Death Dis. 2017 May 18;8(5):e2790.
   PubMedGoogle Scholar
• Calon A, Tauriello DV, Batlle E. TGF-beta in CAF-mediated tumor growth and metastasis. Semin Cancer Biol. 2014 Apr;25:15–22.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hwang YS. Cancer-associated fibroblast stimulates cancer cell invasion in an interleukin-1 receptor (IL-1R)-dependent manner. Oncol Lett. 2019 Nov;18(5):4645–4650.
   PubMed Web of Science ®Google Scholar
• Ham IH, Oh HJ, Jin H, et al. Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in GC. Mol Cancer. 2019 Mar 30;18(1):68.
   PubMedGoogle Scholar
• Andersson P, Yang Y, Hosaka K, et al. Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis. JCI Insight. 2018;3(20):e122375.
   PubMed Web of Science ®Google Scholar
• Taniguchi S, Elhance A, Van Duzer A, et al. Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression. Science. 2020;369(6501):eaay1813.
   PubMed Web of Science ®Google Scholar
• Xiao T, Jie Z. MiR-21 promotes the invasion and metastasis of GC cells by activating epithelial-mesenchymal transition. Eur Surg Res. 2019 Nov;13:1–11.
   Google Scholar
• Wei C, Gao JJ. Downregulated miR-383-5p contributes to the proliferation and migration of GC cells and is associated with poor prognosis. PeerJ. 2019 Oct 15;7:e7882.
   PubMed Web of Science ®Google Scholar
• Jin Y, and Ni S. miR-496 remedies hypoxia reoxygenation-induced H9c2 cardiomyocyte apoptosis via Hook3-targeted PI3k/Akt/mTOR signaling pathway activation. J Cell Biochem. 2020 Jan;121(1): ;698–712.
   PubMed Web of Science ®Google Scholar
• Ma R, Zhu P, Liu S, et al. miR-496 suppress tumorigenesis via targeting BDNF-mediated PI3K/Akt signaling pathway in non-small cell lung cancer. Biochem Biophys Res Commun. 2019 Oct 15;518(2):273–277.
   PubMed Web of Science ®Google Scholar